Literature DB >> 7916380

Serum gamma-glutamyl transferase level in predicting hypertension among male drinkers.

K Miura1, H Nakagawa, H Nakamura, M Tabata, H Nagase, M Yoshida, S Kawano.   

Abstract

In a 10 year prospective study, we investigated the utility of the level of serum gamma-glutamyl transferase (GGT), a biological marker of alcohol consumption, in predicting the development of hypertension in Japanese male drinkers, all of whom lived in a rural community. The study included 77 men, aged 30-69 years, who were normotensive (SBP < or = 140 mmHg and DBP < or = 90 mmHg) and who had no prior history of antihypertensive treatment at baseline (1979-80). Hypertension was defined as SBP of > 140 mmHg and/or DBP of > 90 mmHg and/or starting antihypertensive medication. The age-adjusted relative risk for subjects with a serum GGT level of 20 U/l or higher compared with those with a level of < 10 U/l was 4.18 (95% confidence interval, 1.59-11.01, P = 0.004). The relative risk remained significant after adjustment for baseline BP level and the amount of alcohol consumption. These results suggest that the serum GGT levels may predict the future development of hypertension among drinkers.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7916380

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  13 in total

1.  Body fat distribution, liver enzymes, and risk of hypertension: evidence from the Western New York Study.

Authors:  Saverio Stranges; Maurizio Trevisan; Joan M Dorn; Jacek Dmochowski; Richard P Donahue
Journal:  Hypertension       Date:  2005-10-03       Impact factor: 10.190

2.  Gamma-glutamyltransferase and diabetes--a 4 year follow-up study.

Authors:  D-H Lee; M-H Ha; J-H Kim; D C Christiani; M D Gross; M Steffes; R Blomhoff; D R Jacobs
Journal:  Diabetologia       Date:  2003-03-01       Impact factor: 10.122

3.  Lifestyle modifications to prevent and control hypertension. 3. Recommendations on alcohol consumption. Canadian Hypertension Society, Canadian Coalition for High Blood Pressure Prevention and Control, Laboratory Centre for Disease Control at Health Canada, Heart and Stroke Foundation of Canada.

Authors:  N R Campbell; M J Ashley; S G Carruthers; Y Lacourcière; D W McKay
Journal:  CMAJ       Date:  1999-05-04       Impact factor: 8.262

4.  Low fasting serum insulin in Japanese alcohol consumers does not imply improved coronary risk factors.

Authors:  Yuichi Yamada; Yuka Noborisaka; Masao Ishizaki; Ikiko Tsuritani; Ryumon Honda
Journal:  Environ Health Prev Med       Date:  2004-11       Impact factor: 3.674

5.  Can persistent organic pollutants explain the association between serum gamma-glutamyltransferase and type 2 diabetes?

Authors:  D-H Lee; M W Steffes; D R Jacobs
Journal:  Diabetologia       Date:  2007-12-11       Impact factor: 10.122

Review 6.  Gamma-glutamyltransferase level and risk of hypertension: a systematic review and meta-analysis.

Authors:  Cun-Fei Liu; Yu-Ting Gu; Hai-Ya Wang; Ning-Yuan Fang
Journal:  PLoS One       Date:  2012-11-07       Impact factor: 3.240

7.  Association between γ-glutamyltransferase and prehypertension.

Authors:  Xuzhen Qin; Guodong Tang; Ling Qiu; Tao Xu; Xinqi Cheng; Shaomei Han; Guangjin Zhu; Yajun Liu
Journal:  Mol Med Rep       Date:  2012-01-20       Impact factor: 2.952

8.  Relationship between gamma-glutamyl transferase and glucose intolerance in first degree relatives of type 2 diabetics patients.

Authors:  Sassan Haghighi; Massoud Amini; Zahra Pournaghshband; Peyvand Amini; Silva Hovsepian
Journal:  J Res Med Sci       Date:  2011-02       Impact factor: 1.852

Review 9.  Endobiogeny: a global approach to systems biology (part 1 of 2).

Authors:  Jean-Claude Lapraz; Kamyar M Hedayat
Journal:  Glob Adv Health Med       Date:  2013-01

10.  Elevated Serum Gamma-Glutamyltransferase (GGT) Activity and the Development of Chronic Kidney Disease (CKD) in Cigarette Smokers.

Authors:  Yuka Noborisaka; Masao Ishizaki; Michiko Yamazaki; Ryumon Honda; Yuichi Yamada
Journal:  Nephrourol Mon       Date:  2013-11-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.